Featured Research

from universities, journals, and other organizations

Malaria research must be based in Africa, researcher urges

Date:
February 22, 2010
Source:
University of Gothenburg
Summary:
Organizations supporting medical research in Africa, for example research on malaria, cannot assume that scientific results are independent of time and space. Instead the results reflect the interplay between the research environment, researchers and the study object, according to new research.

Gunilla Priebe has studied the international research alliance the Multilateral Initiative on Malaria (MIM), which advocates for malaria research in general and the strengthening of research environments in Africa. Malaria research has historically been controlled by interests located in areas outside Africa. This has led to a huge gap in knowledge in relation to the malaria problems that dominate everyday life in those areas where people are most affected by the disease.

Better opportunities for researchers on site

According to MIM, researchers based in Africa have a more comprehensive understanding of malaria and its effects on the population. In addition, a locally based researcher is often more motivated to solve problems that are of considerable significance for the majority of malaria patients.

"Proximity to the environment where the social, political, economic as well as the biological dynamics related to malaria are evident provides the researcher with better opportunities to formulate relevant research questions. If the research is based in Africa it increases the chances of the results being of some practical use," says Gunilla Priebe.

Africanisation brings fresh approach

Gunilla Priebe's analysis is framed by the concept of "Africanisation," which in relation to scientific knowledge production entails two integrated themes: the meaning of time and location with regard to researchers' ability to represent a study object correctly and in a relevant manner, and partly the impact of remnants of colonialism on the production of scientific knowledge.

According to Gunilla Priebe, the study of MIM shows that Africanisation of malaria research means investments in infrastructure, education and improved forms for research cooperation. In such a case, Africanisation will also lead to innovative approaches when it comes to research methods and arguments, as well as enhanced influence from both patient and researcher groups that have in the past been marginalised within malaria research.

Definition of researcher's role

Based on the conclusions drawn from Theory of science study of MIM, Gunilla Priebe's recommendation to research organisations, such as philanthropic foundations and national aid and research bodies, is to evaluate the role of research for development in the same way as other "foreign" initiated development cooperation.

"Naturally more money for research into malaria is welcomed, but if the organisations that support research in and about Africa don't intend to reproduce colonial methods, then these cannot work on the basis of Utopian ideals of scientific autonomy. They must also take such issues as the right to co-ownership at each stage of knowledge production into consideration. Neither can they focus solely on financial support or the content and organisation of the research; they must also engage with the political and social effects of research and research support," says Gunilla Priebe.

Title of thesis: Africanising Scientific Knowledge. MIM and malaria research in post-colonial dilemma.


Story Source:

The above story is based on materials provided by University of Gothenburg. Note: Materials may be edited for content and length.


Cite This Page:

University of Gothenburg. "Malaria research must be based in Africa, researcher urges." ScienceDaily. ScienceDaily, 22 February 2010. <www.sciencedaily.com/releases/2010/02/100222104947.htm>.
University of Gothenburg. (2010, February 22). Malaria research must be based in Africa, researcher urges. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/02/100222104947.htm
University of Gothenburg. "Malaria research must be based in Africa, researcher urges." ScienceDaily. www.sciencedaily.com/releases/2010/02/100222104947.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins